Litigation

Recent Posts

Glaxo To Plead Guilty, Will Pay $3 Billion Stemming From Drug Marketing
Posted on 2 Jul 2012 by Tom Moylan

BOSTON - (Mealey's) GlaxoSmithKline LLC (GSK) agreed June 2 to plead guilty and to pay $3 billion to resolve broad-ranging criminal and civil allegations in Massachusetts federal court regarding the promotion of several prescription drugs, failure... Read More

Tags: diabetes drug , Lotronex , Wellbutrin , drugs , GlaxoSmithKline LLC , False Claims Act , United States ex rel. Greg Thorpe v. GlaxoSmithKline PLC , Imitrex , Valtrex , Paxil , antidepressants , United States of America v. GlaxoSmithKline LLC , U.S. Department of Justice , U.S. Food and Drug Administration , Litigation , GSK , Flovent , prescription drugs , Avandia

$2.36B Glaxo Charge Covers Avandia, Paxil Litigation, Other Legal Costs
Posted on 15 Jul 2010 by Tom Moylan

LONDON - (Mealey's) GlaxoSmithKline PLC (GSK) on July 15 said it expects to take a $2.36 billion charge against earnings to settle several legal issues, including settling "the substantial majority" of Avandia product liability cases and... Read More

Tags: diabetes drug , Mealey’s , drugs , drugs & devices , U.S. Securities and Exchange Commission , personal injury , Paxil , paroxetine , product liability , Apotex , Litigation , GSK , GlaxoSmithKline , lawsuit , Glaxo , antidepressant , torts , Avandia

Glaxo Takes $2.36 Billion Charge On Legal Costs
Posted on 15 Jul 2010 by LexisNexis Litigation Resource Community Staff

LONDON - (AP) Pharmaceutical company GlaxoSmithKline said Thursday it expects to take a $2.36 billion charge against second-quarter earnings for the costs of settling court cases over the antidepressant Paxil and diabetes drug Avandia. The company said... Read More

Tags: diabetes drug , European Medicines Agency , birth defects , Paxil , settlements , U.S. Food and Drug Administration , Apotex , Litigation , GSK , GlaxoSmithKline , lawsuit , pharmaceutical , antidepressant , Avandia

Glaxo Settles Bad Drug Claim For More Than $40 Million
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

PROVIDENCE, R.I. - (AP) The American subsidiary of a major British drug maker, GlaxoSmithKline LLC, has agreed to pay more than $40 million to 37 states and Washington, D.C., to settle complaints alleging manufacturing process issues at a now-shuttered... Read More

Tags: diabetes drug , drugs , SB Pharmco , health care , Food and Drug Administration , anti-nausea drug , Paxil , drug maker , Bactroban , Cidra , Medicaid , Avandamet , Litigation , GlaxoSmithKline , antibiotic , antidepressant , Puerto Rico , Kytril